Group One Trading’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-200
| Closed | -$3.15K | – | 7703 |
|
|
2024
Q1 | $3.15K | Sell |
200
-20,700
| -99% | -$319K | ﹤0.01% | 6359 |
|
|
2023
Q4 | $337K | Buy |
20,900
+20,700
| +10,350% | +$264K | ﹤0.01% | 3401 |
|
|
2023
Q3 | $2.54K | Sell |
200
-400
| -67% | -$5.52K | ﹤0.01% | 6968 |
|
|
2023
Q2 | $8.45K | Buy |
600
+300
| +100% | +$4.29K | ﹤0.01% | 6475 |
|
|
2023
Q1 | $4.63K | Sell |
300
-2,900
| -91% | -$48.4K | ﹤0.01% | 6312 |
|
|
2022
Q4 | $52.4K | Hold |
3,200
| – | – | ﹤0.01% | 4955 |
|
|
2022
Q3 | $59K | Sell |
3,200
-4,500
| -58% | -$70.6K | ﹤0.01% | 5268 |
|
|
2022
Q2 | $101K | Sell |
7,700
-6,000
| -44% | -$66.2K | ﹤0.01% | 4985 |
|
|
2022
Q1 | $127K | Sell |
13,700
-47,500
| -78% | -$404K | ﹤0.01% | 5267 |
|
|
2021
Q4 | $598K | Buy |
61,200
+60,000
| +5,000% | +$1.13M | ﹤0.01% | 3918 |
|
|
2021
Q3 | $41K | Sell |
1,200
-700
| -37% | -$22.3K | ﹤0.01% | 6704 |
|
|
2021
Q2 | $70K | Sell |
1,900
-9,100
| -83% | -$352K | ﹤0.01% | 6295 |
|
|
2021
Q1 | $493K | Sell |
11,000
-20,500
| -65% | -$954K | ﹤0.01% | 4053 |
|
|
2020
Q4 | $1.8M | Buy |
31,500
+13,400
| +74% | +$794K | ﹤0.01% | 2142 |
|
|
2020
Q3 | $929K | Buy |
18,100
+2,800
| +18% | +$137K | ﹤0.01% | 2263 |
|
|
2020
Q2 | $914K | Buy |
15,300
+500
| +3% | +$26.7K | ﹤0.01% | 2105 |
|
|
2020
Q1 | $609K | Sell |
14,800
-5,800
| -28% | -$322K | ﹤0.01% | 1910 |
|
|
2019
Q4 | $1.28M | Buy |
20,600
+17,200
| +506% | +$817K | 0.01% | 1671 |
|
|
2019
Q3 | $115K | Buy |
+3,400
| New | +$101K | ﹤0.01% | 3468 |
|
|
2018
Q4 | – | Sell |
-100
| Closed | -$4K | – | 5535 |
|
|
2018
Q3 | $4K | Buy |
+100
| New | +$3.69K | ﹤0.01% | 4921 |
|
Other funds holding DCPH
Group One Trading's DCPH Position: Q2 2024 in Review
Group One Trading sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 705 shares — an estimated $11.1K sold.
Group One Trading first reported a position in DCPH in Q3 2018 and held it in 12 quarters. The position peaked at $743K in Q4 2019. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Group One Trading reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Group One Trading sold 705 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $11.1K.
- Group One Trading first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2018 and held it in 12 quarters.
- Group One Trading's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $743K in Q4 2019.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Group One Trading's 13F filing for Q2 2024, filed 14 Aug 2024.